Alan Metz

3.6k total citations
55 papers, 2.6k citations indexed

About

Alan Metz is a scholar working on Pharmacology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Alan Metz has authored 55 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Physiology and 9 papers in Psychiatry and Mental health. Recurrent topics in Alan Metz's work include Treatment of Major Depression (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Schizophrenia research and treatment (4 papers). Alan Metz is often cited by papers focused on Treatment of Major Depression (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Schizophrenia research and treatment (4 papers). Alan Metz collaborates with scholars based in United States, United Kingdom and Switzerland. Alan Metz's co-authors include John E. Dohms, Brenda D. Jamerson, Rafe Donahue, Carolyn Watson, Robert A. Leadbetter, J. Μ. Sharma, Harry A. Croft, James F. Pradko, Anita H. Clayton and C. Brendan Montano and has published in prestigious journals such as The Lancet, Blood and The Journal of Immunology.

In The Last Decade

Alan Metz

55 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Metz United States 26 745 461 457 360 321 55 2.6k
Moisés Evandro Bauer Brazil 43 1.2k 1.7× 197 0.4× 616 1.3× 607 1.7× 151 0.5× 134 5.0k
E. Bosmans Belgium 38 611 0.8× 198 0.4× 368 0.8× 540 1.5× 121 0.4× 97 4.3k
Abdulla A.‐B. Badawy United Kingdom 36 665 0.9× 307 0.7× 633 1.4× 1.4k 3.8× 334 1.0× 131 4.4k
Sandra Odebrecht Vargas Nunes Brazil 28 850 1.1× 179 0.4× 358 0.8× 418 1.2× 101 0.3× 78 3.1k
Rainer Lüdtke Germany 38 404 0.5× 1.3k 2.8× 574 1.3× 574 1.6× 186 0.6× 160 4.9k
Akiko Okamoto Japan 34 505 0.7× 530 1.1× 1.0k 2.2× 917 2.5× 177 0.6× 156 4.3k
Bent Nørgaard‐Pedersen Denmark 36 281 0.4× 212 0.5× 254 0.6× 900 2.5× 430 1.3× 115 4.4k
J. Raus Belgium 41 370 0.5× 283 0.6× 281 0.6× 849 2.4× 1.2k 3.8× 149 5.4k
Sudesh Prabhakar India 34 418 0.6× 279 0.6× 396 0.9× 624 1.7× 570 1.8× 185 3.7k
David Robertson United States 35 423 0.6× 246 0.5× 1.0k 2.3× 394 1.1× 172 0.5× 124 4.7k

Countries citing papers authored by Alan Metz

Since Specialization
Citations

This map shows the geographic impact of Alan Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Metz more than expected).

Fields of papers citing papers by Alan Metz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Metz. The network helps show where Alan Metz may publish in the future.

Co-authorship network of co-authors of Alan Metz

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Metz. A scholar is included among the top collaborators of Alan Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Metz. Alan Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Apter, Alan, Alan Lipschitz, Regan Fong, et al.. (2006). Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 77–90. 21 indexed citations
2.
Modell, Jack G., Norman E. Rosenthal, Alok Krishen, et al.. (2005). Seasonal Affective Disorder and Its Prevention by Anticipatory Treatment with Bupropion XL. Biological Psychiatry. 58(8). 658–667. 80 indexed citations
3.
Weihs, Karen L., Trisha L. Houser, Sharyn R. Batey, et al.. (2002). Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biological Psychiatry. 51(9). 753–761. 54 indexed citations
4.
Jain, Adesh K., Roy A. Kaplan, Kishore M. Gadde, et al.. (2002). Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms. Obesity Research. 10(10). 1049–1056. 145 indexed citations
5.
Croft, Harry A., Trisha L. Houser, Brenda D. Jamerson, et al.. (2002). Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clinical Therapeutics. 24(4). 662–672. 47 indexed citations
6.
Rush, A. John, Sharyn R. Batey, Rafe Donahue, et al.. (2001). Does pretreatment anxiety predict response to either bupropion SR or sertraline?. Journal of Affective Disorders. 64(1). 81–87. 24 indexed citations
7.
Trivedi, Madhukar H., A. John Rush, Thomas Carmody, et al.. (2001). Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients?. The Journal of Clinical Psychiatry. 62(10). 776–781. 56 indexed citations
8.
Fuseau, Eliane, Olivier Pétricoul, Adrian Pereira, et al.. (2001). Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine. Clinical Therapeutics. 23(2). 242–251. 31 indexed citations
9.
Schimmer, Ralph C., Denis J. Schrier, Craig M. Flory, et al.. (1998). Streptococcal Cell Wall-Induced Arthritis: Requirements for IL-4, IL-10, IFN-γ, and Monocyte Chemoattractant Protein-1. The Journal of Immunology. 160(3). 1466–1471. 18 indexed citations
10.
Chi, Liguo, et al.. (1998). A novel model of venous thrombosis in the vena cava of rabbits. Journal of Pharmacological and Toxicological Methods. 39(4). 193–202. 8 indexed citations
11.
Wallace, John L., et al.. (1995). Cytoprotective effects of CI-959 in the rat gastric mucosa: Modulation of leukocyte adhesion. Gastroenterology. 109(4). 1224–1233. 9 indexed citations
12.
Metz, Alan, Scott P. Henry, Gordon Loewen, et al.. (1995). Cardiac Hypertrophy in Rats After Intravenous Administration of CI-959, a Novel Antiinflammatory Compound. Journal of Cardiovascular Pharmacology. 25(6). 930–939. 1 indexed citations
13.
Metz, Alan & Richard I. Shader. (1991). Combination of Fluoxetine with Pemoline in the Treatment of Major Depressive Disorder. International Clinical Psychopharmacology. 6(2). 93–96. 17 indexed citations
14.
Dohms, John E. & Alan Metz. (1991). Stress — mechanisms of immunosuppression. Veterinary Immunology and Immunopathology. 30(1). 89–109. 130 indexed citations
15.
Metz, Alan. (1991). Manual of Clinical Psychopharmacology. Journal of Clinical Psychopharmacology. 11(5). 333–333. 16 indexed citations
16.
Metz, Alan & Richard I. Shader. (1990). Adverse Interactions Encountered when Using Trazodone to Treat Insomnia Associated with Fluoxetine. International Clinical Psychopharmacology. 5(3). 191–194. 25 indexed citations
17.
Reidarson, Thomas H., Alan Metz, & Robert Hardy. (1988). Thoracic vertebral osteochondroma in a cat. Journal of the American Veterinary Medical Association. 192(8). 1102–1104. 9 indexed citations
18.
Horvath, Christopher, et al.. (1988). Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse. Journal of the American Veterinary Medical Association. 192(3). 367–371. 12 indexed citations
19.
Metz, Alan, et al.. (1987). Inhibition of the rate of GABA synthesis in regions of rat brain following a convulsion. British Journal of Pharmacology. 92(1). 5–11. 35 indexed citations
20.
Metz, Alan, et al.. (1984). Chronic suppurative orchiepididymitis associated with Haemophilus somnus in a calf. Journal of the American Veterinary Medical Association. 184(12). 1507–1508. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moisés Evandro Bauer Breakdown of academic impact, for papers by E. Bosmans Breakdown of academic impact, for papers by Abdulla A.‐B. Badawy Breakdown of academic impact, for papers by Sandra Odebrecht Vargas Nunes Breakdown of academic impact, for papers by Rainer Lüdtke Breakdown of academic impact, for papers by Akiko Okamoto Breakdown of academic impact, for papers by Bent Nørgaard‐Pedersen Breakdown of academic impact, for papers by J. Raus Breakdown of academic impact, for papers by Sudesh Prabhakar Breakdown of academic impact, for papers by David Robertson
Rankless by CCL
2026